Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5696488 | 0.73 | AKT1 (0.36) | HRH3 | |
| SCHEMBL8407004 | 0.72 | HRH3 (0.36) | SLC6A2SLC6A4SLC6A3HRH3CYP11B1 | |
| SCHEMBL1995772 | 0.70 | NOS2 (0.47) | SLC6A2SLC6A4SLC6A3HRH3CYP11B1 | |
| SCHEMBL7814379 | 0.69 | RAPGEF4 (0.36) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8388464 | 0.69 | NOS2 (0.42) | HRH3CYP11B1CYP11B2 | |
| SCHEMBL113792 | 0.68 | NOS2 (0.37) | SLC6A2SLC6A4SLC6A3HRH3CYP11B1 | |
| SCHEMBL29600917 | 0.68 | SLC6A2 (0.39) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL95192 | 0.68 | HRH3 (0.40) | HRH3CYP11B1CYP11B2 | |
| SCHEMBL13021414 | 0.66 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13021415 | 0.66 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10981878-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2021-04-20 | — | — | US | disclosed |
| US-10975038-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2021-04-13 | — | — | US | disclosed |
| US-10919860-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2021-02-16 | — | — | US | disclosed |
| US-10913723-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2021-02-09 | — | — | US | disclosed |
| US-20180370920-A1 | BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2018-12-27 | — | — | US | disclosed |
| US-10150738-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2018-12-11 | — | — | US | disclosed |
| US-20180072681-A1 | BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2018-03-15 | — | — | US | disclosed |
| US-9828347-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2017-11-28 | — | — | US | disclosed |
| US-20170247333-A1 | BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2017-08-31 | — | — | US | disclosed |
| US-20160102061-A1 | BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2016-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160102061-A1 | BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES | NUDC, NBAS, NDC1 | SLC6A2 2558/4885SLC6A4 3138/4885SLC6A3 1226/4885 |
| US-20170247333-A1 | BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES | NUDC, NBAS, NDC1 | SLC6A2 2558/4885SLC6A4 3138/4885SLC6A3 1226/4885 |
| US-10975038-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | NUDC, NBAS, NDC1 | SLC6A2 2558/4885SLC6A4 3138/4885SLC6A3 1226/4885 |
| US-20180370920-A1 | BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES | NPM1, NOX3, NUDC | SLC6A2 1641/4885SLC6A4 2512/4885SLC6A3 264/4885 |
| US-10981878-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | NUDC, NBAS, NDC1 | SLC6A2 2558/4885SLC6A4 3138/4885SLC6A3 1226/4885 |
| US-10919860-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | NUDC, NBAS, NDC1 | SLC6A2 2558/4885SLC6A4 3138/4885SLC6A3 1226/4885 |
| US-20180072681-A1 | BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES | NUDC, NBAS, NDC1 | SLC6A2 2558/4885SLC6A4 3138/4885SLC6A3 1226/4885 |
| US-10913723-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | NUDC, NBAS, NDC1 | SLC6A2 2558/4885SLC6A4 3138/4885SLC6A3 1226/4885 |
| US-10150738-B2 | Backfunctionalized imidazolinium salts and NHC carbene-metal complexes | NUDC, NBAS, NDC1 | SLC6A2 2558/4885SLC6A4 3138/4885SLC6A3 1226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.